Global Animal Health Market Edition 2025: Industry Size to Reach USD 51.33 Billion by 2033, CAGR of 2.79%

According to the latest report by IMARC Group, titled "Animal Health Market Size, Share, Trends and Forecast by Animal Type, Product Type, and Region, 2025-2033", offers a comprehensive analysis of the industry, which comprises insights on the global animal health market size. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global animal health market size was valued at USD 38.99 Billion in 2024. Looking forward, the market is projected to reach USD 51.33 Billion by 2033, exhibiting a CAGR of 2.79% during 2025-2033. North America currently dominates the market, holding a significant market share of 44.9% in 2024.

Request Free Sample Report: https://www.imarcgroup.com/animal-health-market/requestsample

Global Animal Health Market Dynamics:

Increasing Companion Animal Ownership and Expenditure:

One of the primary drivers of growth in the global animal health market is the increasing awareness of pet care in urban regions across the globe. Dogs, cats and other pets are now being considered and treated as part of families. This tendency drives higher spending on their health and well-being. As a result, there is a growing supply and demand of veterinary services, premium pet foods with healthful ingredients, and preventative and therapeutic wellness products for pet animals. This expenditure boom in veterinary services and pet care significantly propels the growth of animal health markets.

Growing Livestock Population and Intensified Production:

The mounting population in the world results in an increased supply of animal protein in the form of meat, dairy products, and eggs. In turn, this increases the requirements for adequate animal health for productive livestock. Animal welfare under intensive farming systems aimed to maximize efficiency also increases the animals' susceptibility to diseases. Thus, there is a continually growing need for livestock vaccines, parasiticides, nutritional supplements, and other disease management tools. Keeping a healthy population of livestock is essential for food safety, thus animal health becomes important for the agricultural economy.

Rising Awareness of Zoonotic Diseases and Food Safety:

The rise in concern for zoonotic diseases, which cross infect animals and humans, as well as increased focus on food safety, are important market drivers. Governments and public authorities are more concerned with public health and so are putting stricter requirements on animal health and disease control policies. This level of concern and regulation raises the need of diagnostics, vaccines, and biosecurity for both livestock and companion animals. Safeguarding animal health is essential for animal welfare and productivity and crucial for human health and safe food supply chains.

By the IMARC Group, Some of the Top Competitive Landscape Operating in the Animal Health Market Report are Given Below:

• Bayer
• Elanco
• Merck
• Merial
• Zoetis Inc.
• Biogenesis Bago
• Boehringer Ingelheim
• Ceva Sante Animale
• Heska
• Neogen
• Novartis
• Thermo Fisher Scientific
• Vetoquinol
• Virbac

Contact Out Analysts for Brochure Requests, Customization, and Inquiries Before Purchase: https://www.imarcgroup.com/request?type=report&id=1156&flag=C

Global Animal Health Market Trends:

The current animal health market has several important trends. One of the most prevalent is the adoption of new diagnostic tools for early disease identification. These tools include molecular diagnostics, imaging, and point-of-care testing. Early diagnosis leads to timely intervention which improves outcomes and prevents disease transmission. The increasing emphasis on animal healthcare maintenance is another focus trend. This includes the use of proprietary vaccines, nutritional immunomodulators, and health monitoring to lower the incidence rates of diseases.

Moreover, there is enhanced adoption of new therapeutics and their accompanying biologics, and precision medicines designed for specific animal health issues. The use of digital technologies such as telemedicine and data analytics is also changing the practice of animal healthcare and disease control.

Key Market Segmentation:

Breakup by Animal Type:

• Commercial
• Companion

Breakup by Product Type:

• Pharmaceuticals
• Biologicals
• Medicinal Feed Additives
• Diagnostics

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

• Market Performance
• Market Outlook
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.